Source: Business Wire
Thursday, November 15, 2012 12:17 PM IST (06:47 AM GMT)
Editors: General: Consumer interest; Business: Healthcare, biotechnology & pharmaceutical; Healthcare
--------------------------------------------------
(BW)(NY-TARO-PHARMACEUTICAL)(TARO)(SUNPHARMA)(524715)Taro Postpones Shareholders Meetings on Proposed Merger With Sun Pharma
Hawthorne, New York, United States, Thursday, November 15, 2012 -- (Business Wire India) --
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro") has announced that it has postponed its extraordinary general meeting of shareholders and the class meeting of holders of ordinary shares, originally scheduled for December 6, 2012, to consider the proposed merger of Taro with a subsidiary of Sun Pharmaceutical Industries, Ltd. ("Sun Pharma," Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715). Taro will set a new record date for the rescheduled meetings and will mail a supplemental notice together with proxy materials to its shareholders.
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company's website at www.taro.com.
SAFE HARBOR STATEMENT
Certain statements in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements that do not describe historical facts and statements that refer or relate to events or circumstances Taro "estimates," "believes," or "expects" to happen or similar language. The forward-looking statements in this press release are based on Taro's current expectations and are made only as of the date of this press release and involve certain risks and uncertainties that could cause actual results to differ materially from future results that may be expressed or implied by such forward-looking statements. Unless required by law, Taro undertakes no obligations to update, change or revise any forward-looking statement, whether as a result of new information, additional or subsequent developments or otherwise.
CONTACT DETAILS
CONTACTS :
Taro Pharmaceutical Industries Ltd.
William J. Coote, 914-345-9001
VP, Treasurer
William.Coote@taro.com
KEYWORDS
CONSUMER, HEALTHCARE, HEALTHCARE
If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.
http://www.businesswire.com
Submit your press release at http://www.businesswireindia.com
No comments:
Post a Comment